Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume 35, Issue 22, Pages -
Publisher
Wiley
Online
2023-03-14
DOI
10.1002/adma.202212267
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2023
- (2023) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death
- (2023) Yun Huang et al. Acta Biomaterialia
- Restoration of the Immunogenicity of Tumor Cells for Enhanced Cancer Therapy via Nanoparticle‐Mediated Copper Chaperone Inhibition
- (2022) Feixiang Ding et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing
- (2022) Brendan W. MacNabb et al. IMMUNITY
- Cuproptosis: Cellular and molecular mechanisms underlying copper-induced cell death
- (2022) Paul A. Cobine et al. MOLECULAR CELL
- Copper-induced cell death
- (2022) Martha A. Kahlson et al. SCIENCE
- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- Biomedical polymers: synthesis, properties, and applications
- (2022) Wei-Hai Chen et al. Science China-Chemistry
- Camrelizumab plus famitinib for advanced or metastatic urothelial carcinoma after platinum-based therapy: data from a multicohort phase 2 study
- (2022) Yuan-Yuan Qu et al. Journal for ImmunoTherapy of Cancer
- A Hollow Amorphous Bimetal Organic Framework for Synergistic Cuproptosis/Ferroptosis/Apoptosis Anticancer Therapy via Disrupting Intracellular Redox Homeostasis and Copper/Iron Metabolisms
- (2022) Weijun Xu et al. ADVANCED FUNCTIONAL MATERIALS
- Self‐Sacrificially Degradable Pseudo‐Semiconducting Polymer Nanoparticles that Integrate NIR‐II Fluorescence Bioimaging, Photodynamic Immunotherapy, and Photo‐Activated Chemotherapy
- (2022) Dongsheng Tang et al. ADVANCED MATERIALS
- Macrophages as tools and targets in cancer therapy
- (2022) Alberto Mantovani et al. NATURE REVIEWS DRUG DISCOVERY
- The dynamic roles of the bladder tumour microenvironment
- (2022) Yu-Cheng Lee et al. Nature Reviews Urology
- Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma
- (2022) Yongyun Li et al. ONCOGENE
- Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy
- (2022) Haiqin Song et al. JOURNAL OF NANOBIOTECHNOLOGY
- Reduction Sensitive Polymers Delivering Cationic Platinum Drugs as STING Agonists for Enhanced Chemo‐Immunotherapy
- (2022) Lingpu Zhang et al. ADVANCED FUNCTIONAL MATERIALS
- Unraveling and Overcoming Platinum Drug‐Resistant Cancer Tumors with DNA Nanostructures
- (2022) Yingjie Yu et al. ADVANCED FUNCTIONAL MATERIALS
- An Enzyme‐Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis‐Based Synergistic Cancer Therapy
- (2022) Yuzhi Xu et al. ADVANCED MATERIALS
- Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
- (2022) Peijie Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- An intercellular transfer of telomeres rescues T cells from senescence and promotes long-term immunological memory
- (2022) Alessio Lanna et al. NATURE CELL BIOLOGY
- Tetrahedral DNA Nanostructure with Interferon Stimulatory DNA Delivers Highly Potent Toxins and Activates the cGAS‐STING Pathway for Robust Chemotherapy and Immunotherapy
- (2022) Lingpu Zhang et al. ADVANCED MATERIALS
- Photothermally Triggered Copper Payload Release for Cuproptosis‐Promoted Cancer Synergistic Therapy
- (2022) Jie Zhou et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
- (2022) Xuhui Tong et al. Journal of Hematology & Oncology
- Brain‐Targeted HFn‐Cu‐REGO Nanoplatform for Site‐Specific Delivery and Manipulation of Autophagy and Cuproptosis in Glioblastoma
- (2022) Wenhui Jia et al. Small
- Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy
- (2022) Lingpu Zhang et al. Advanced Science
- A Systematic Strategy of Combinational Blow for Overcoming Cascade Drug Resistance via NIR‐Light‐Triggered Hyperthermia
- (2021) Lingna Wang et al. ADVANCED MATERIALS
- Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
- (2021) Thomas Powles et al. LANCET ONCOLOGY
- Biodegradable Polymer with Effective Near‐Infrared‐II Absorption as a Photothermal Agent for Deep Tumor Therapy
- (2021) Yingjie Yu et al. ADVANCED MATERIALS
- Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic
- (2021) Amit Grover et al. Cancer Discovery
- Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 Dysfunction
- (2020) Kohei Kobatake et al. CLINICAL CANCER RESEARCH
- Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
- (2020) Julieta Afonso et al. Nature Reviews Urology
- Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
- (2020) Matthew D Galsky et al. LANCET
- Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer
- (2020) David Y. Oh et al. CELL
- Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion
- (2020) Florida Voli et al. CANCER RESEARCH
- X-ray structures of the high-affinity copper transporter Ctr1
- (2019) Feifei Ren et al. Nature Communications
- Mitochondrial metabolism promotes adaptation to proteotoxic stress
- (2019) Peter Tsvetkov et al. Nature Chemical Biology
- The multifaceted immune regulation of bladder cancer
- (2019) Anna K. Schneider et al. Nature Reviews Urology
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Zinc and Copper Levels in Bladder Cancer: A Systematic Review and Meta-Analysis
- (2013) Song Mao et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells
- (2012) Masazumi Nagai et al. FREE RADICAL BIOLOGY AND MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search